MedPath

Prospective Trial Evaluating the Effect of Closed Suction Drainage Versus Straight Drainage After Distal Pancreatectomy

Not Applicable
Terminated
Conditions
Pancreatic Fistula
Registration Number
NCT02343302
Lead Sponsor
Johns Hopkins University
Brief Summary

A very common complication following distal pancreatectomy is leakage from the pancreas, or what is called a pancreatic fistula. We hypothesize that operative drains which create suction may contribute to the development of leakage from the pancreas. This study evaluates the effect of using non-suctioning drains to prevent the development of this complication.

Detailed Description

The most common complication following distal pancreatectomy is the developement of leakage from the remaining pancreas gland, which results in significant morbidity. Most surgeons leave dains at the time of surgery to prevent complications from pancreatic leakage. However, we hypothesize that drains which create continous negative pressure may contribute to the development of a pancreatic fistula. This study randomizes patients to suctioning versus non-suctioning drains. The primary endpoint is the development of pancreatic fistuale, as defined by the International Study Group of Pancreatic Surgery.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Patients undergoing distal pancreatectomy at Johns Hopkins Hospital
Exclusion Criteria
  • Children <18 years old, pregnant women, adults lacking capacity to consent, non-english speakers, and prisoners.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Post-operative Pancreatic Fistula90 days

The primary endpoint of the study is the developement of post-operative pancreatic fistula, as defined by the International Study Group of Pancreatic Surgery.

Secondary Outcome Measures
NameTimeMethod
Morbidity90 days

All morbidity, including length of hospital stay, need for enteral/parenteral nutrition, need for radiologic/surgical intervention, septic complications, and peri-operative mortality.

Trial Locations

Locations (1)

Johns Hopkins Hospital

🇺🇸

Baltimore, Maryland, United States

Johns Hopkins Hospital
🇺🇸Baltimore, Maryland, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.